Drug: |
INBRX-109 + Temozolomide |
|||
---|---|---|---|---|
Trial: |
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
HonorHealth Virginia Piper Cancer Center10460 N. 92nd St. |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.